Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats

被引:6
作者
Boughattas, NA [1 ]
Ben Attia, M
Ixart, G
Lemaigre, G
Mechkouri, M
Reinberg, A
机构
[1] Fac Med, Pharmacol Lab, Monastir 5019, Tunisia
[2] Hop Paul Brousse, Lab Rythmes Biol & Chronotherapeut, F-94800 Villejuif, France
[3] Fac Sci Bizerte, Dept Sci Vie, Zarzouna 7021, Tunisia
[4] Univ Montpellier 2 USTL, CNRS, U97, Lab Neurobiol Endocrinol, F-34095 Montpellier 05, France
[5] Hop Antoine Beclere, Anat Pathol Lab, Clamart 92, France
[6] Fdn A de Rothschild, Unite Chronobiol, F-75940 Paris 19, France
关键词
chronopharmacology; chronotoxicology; circadian rhythm; oxaliplatin toxicity; para-chlorophenylalanine; serotoninergic system; suprachiasmatic nuclei;
D O I
10.1081/CBI-120015957
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study investigates if the serotoninergic system plays a role in chronotoxic effects of the anticancer agent oxaliplatin (l-OHP). Four groups of female rats (120 in total) synchronized with light-dark (12h:12h) were treated with: (i) saline, (ii) para-chlorophenylalanine (pCPA, an inhibitor of serotonin biosynthesis: 300 mg/kg/d, i.p. for two consecutive days), (iii) l-OHP (23 mg/kg, i.v.) at three different dosing times, or (iv) both pCPA and l-OHP. The results show pCPA (iii) obliterates the circadian rhythm in plasma ACTH but not in corticosterone or leukocytes, and (iii) l-OHP exerts circadian time-dependent toxic effects (body weight loss, leukopenia, and intestinal lesions) with greatest toxicity coinciding with treatment at the end of the nocturnal activity span (P<0.05). In rats whose serotonin biosynthesis was blocked (iv), the circadian rhythms in the toxic effects of l-OHP and in ACTH were obliterated, while the rhythms in corticosterone and leukocytes persisted.
引用
收藏
页码:1121 / 1136
页数:16
相关论文
共 30 条
[1]  
BLATTER F, 1986, ANN REV CHRONOPHARMA, V3, P5
[2]  
BOUGHATTAS NA, 1989, CANCER RES, V49, P3362
[3]   CIRCADIAN TIME-DEPENDENCE OF MURINE TOLERANCE FOR CARBOPLATIN [J].
BOUGHATTAS, NA ;
LEVI, F ;
HECQUET, B ;
LEMAIGRE, G ;
ROULON, A ;
FOURNIER, C ;
REINBERG, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 96 (02) :233-247
[4]   COMPARATIVE PHARMACOKINETICS OF OXALIPLATIN (L-OHP) AND CARBOPLATIN (CBDCA) IN MICE WITH REFERENCE TO CIRCADIAN DOSING TIME [J].
BOUGHATTAS, NA ;
HECQUET, B ;
FOURNIER, C ;
BRUGUEROLLE, B ;
TRABELSI, H ;
BOUZOUITA, K ;
OMRANE, B ;
LEVI, F .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (09) :761-773
[5]   Modulation of cisplatin chronotoxicity related to reduced glutathione in mice [J].
Boughattas, NA ;
Li, XM ;
Filipski, J ;
Lemaigre, G ;
Filipski, E ;
Bouzouita, K ;
Belhadj, O ;
Levi, F .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1996, 15 (07) :563-572
[6]  
BOUGHATTAS NA, 1990, J PHARMACOL EXP THER, V255, P672
[7]  
BOUGHATTAS NA, 1989, THESIS U PARIS 7 PAR
[8]   PHASE-I TRIAL OF 5-DAY CONTINUOUS VENOUS INFUSION OF OXALIPLATIN AT CIRCADIAN RHYTHM-MODULATED RATE COMPARED WITH CONSTANT RATE [J].
CAUSSANEL, JP ;
LEVI, F ;
BRIENZA, S ;
MISSET, JL ;
ITZHAKI, M ;
ADAM, R ;
MILANO, G ;
HECQUET, B ;
MATHE, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) :1046-1050
[9]   SIGHTSEEING AROUND THE SINGLE COSINOR [J].
DEPRINS, J ;
WALDURA, J .
CHRONOBIOLOGY INTERNATIONAL, 1993, 10 (05) :395-400
[10]   Chronobiological concepts underlying the chronotherapy of human lung cancer [J].
Focan, C .
CHRONOBIOLOGY INTERNATIONAL, 2002, 19 (01) :253-273